Crisaborole Topical Ointment, 2%, a novel nonsteroidal, anti-inflammatory, topical, phosphodiesterase 4 inhibitor, reduced pruritus and signs of atopic dermatitis in 2 phase 3 studies in children and adults with mild-to-moderate atopic dermatitis

被引：0
|
作者：
Zane, Lee Thomas [1 ]
Hebert, Adelaide A. [2 ]
Eichenfield, Lawrence F. [3 ,4 ]
Lebwohl, Mark G. [5 ]
Paller, Amy S. [6 ]
Simpson, Eric L. [7 ]
Tom, Wynnis L. [3 ,4 ]
Hughes, Matty H. [1 ]
机构：
[1] Anacor Pharmaceut Inc, Palo Alto, CA USA
[2] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[3] Rady Childrens Hosp, San Diego, CA USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
[7] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF IMMUNOLOGY | 2016年 / 196卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] E6005, a Novel Topical Phosphodiesterase 4 Inhibitor, Ameliorated Pruritus and Inflammation in Mouse Atopic Dermatitis Models
    Naoto, Ishii
    Hisashi, Wakita
    Manabu, Shirato
    Ieharu, Hishinuma
    Kazuki, Miyazaki
    Yasutaka, Takase
    Osamu, Asano
    Eiichi, Yamamoto
    Kazutomi, Kusano
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S12 - S12
  • [42] A mild topical steroid leads to progressive anti-inflammatory effects in skin of moderate-to-severe atopic dermatitis
    Brunner, P. M.
    Khattri, S.
    Garcet, S.
    Finney, R.
    Oliva, M.
    Dutt, R.
    Fuentes-Duculan, J.
    Zheng, X.
    Li, X.
    Bonifacio, K. M.
    Kunjravia, N.
    Coats, I.
    Cueto, I.
    Gilleaudeau, P.
    Sullivan-Whalen, M.
    Suarez-Farinas, M.
    Krueger, J. G.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S41 - S41
  • [43] Efficacy and safety trends with continuous long-term use of crisaborole ointment 2% in patients with mild-to-moderate atopic dermatitis
    Lebwohl, M. G.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E100 - E101
  • [44] Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis
    Fahrbach, Kyle
    Tarpey, Jialu
    Washington, Evelien Bergrath
    Hughes, Rachel
    Thom, Howard
    Neary, Maureen P.
    Cha, Amy
    Gerber, Robert
    Cappelleri, Joseph C.
    DERMATOLOGY AND THERAPY, 2020, 10 (04) : 681 - 694
  • [45] 2-Year animal carcinogenicity results for crisaborole, a novel phosphodiesterase 4 inhibitor for atopic dermatitis
    Ciaravino, Vic
    Coronado, Dina
    Lanphear, Cheryl
    Chanda, Sanjay
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 87 (02) : 116 - 122
  • [46] Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis
    Kyle Fahrbach
    Jialu Tarpey
    Evelien Bergrath Washington
    Rachel Hughes
    Howard Thom
    Maureen P. Neary
    Amy Cha
    Robert Gerber
    Joseph C. Cappelleri
    Dermatology and Therapy, 2020, 10 : 681 - 694
  • [47] Efficacy and safety of crisaborole ointment, 2%, in Chinese and Japanese pediatric patients aged 2-17 years with mild-to-moderate atopic dermatitis
    Zhang, Jianzhong
    Ma, Lin
    Wang, Shan
    Li, Ping
    Liang, Yunsheng
    Qian, Qiufang
    Cha, Amy
    Canosa, Juliana M.
    Zhou, Yangmei
    Chen, Yayuan
    Li, Yinghui
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [48] A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS (NMA) OF CRISABOROLE 2% OINTMENT FOR THE TREATMENT OF MILD-TO-MODERATE ATOPIC DERMATITIS (AD)
    Fahrbach, K.
    Tarpey, J.
    Bergrath, E.
    Hughes, R.
    Cha, A.
    Gerber, R.
    Cappelleri, J. C.
    VALUE IN HEALTH, 2019, 22 : S597 - S598
  • [49] Safety, pharmacokinetics and efficacy of AN2728 ointment, 2% in a phase 2 study of adolescents with mild-to-moderate atopic dermatitis
    Zane, L. T.
    Tom, W. L.
    Chanda, S.
    Liu, L.
    Merrie, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S176 - S176
  • [50] A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis
    Brunner, Patrick M.
    Khattri, Saakshi
    Garcet, Sandra
    Finney, Robert
    Oliva, Margeaux
    Dutt, Riana
    Fuentes-Duculan, Judilyn
    Zheng, Xiuzhong
    Li, Xuan
    Bonifacio, Kathleen M.
    Kunjravia, Norma
    Coats, Israel
    Cueto, Inna
    Gilleaudeau, Patricia
    Sullivan-Whalen, Mary
    Suarez-Farinas, Mayte
    Krueger, James G.
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (01) : 169 - 178
12345